NCT04964440View on ClinicalTrials.gov

Redo AF Sub Study (of the Pure EP 2.0 Main Study)

CompletedOBSERVATIONAL
Enrollment

20

Participants

Timeline

Start Date

March 3, 2021

Primary Completion Date

July 20, 2021

Study Completion Date

January 29, 2022

Conditions
Atrial Fibrillation Recurrent
Interventions
DEVICE

Pure-EP

Advanced Signal Acquisition and Processing

Trial Locations (1)

78758

St. David's Medical Center, Austin

Sponsors
All Listed Sponsors
lead

BioSig Technologies, Inc.

INDUSTRY